Literature DB >> 8834553

The case-control study as data missing by design: estimating risk differences.

S Wacholder1.   

Abstract

There are advantages to viewing the case-control design as a missing-data problem instead of as a sampling problem. In the simplest setup, cases are those members of a population who develop disease; controls can be a small random sample of the large number who do not; and covariates, including exposures and other important variables, are available only for cases and controls and are assumed to be missing at random for the remaining large fraction of the population. This approach allows estimation of the joint distribution of all variables in the population. Thus, when the size of the population is known, analysis is not restricted to logistic and other multiplicative intercept models. Methods based on this approach can obtain estimates and confidence intervals for parameters representing the effect of exposure on disease, with multivariate adjustment for other factors. Thus, case-control data can be used to estimate the risk difference, a parameter with great public health value. The missing-data perspective offers an additional advantage by linking the "study base principle" of control selection with the statistical concept of "missing at random." As an illustration, I use a subset of data from a case-control study to obtain estimates of the difference between annual risk of bladder cancer for various levels of smoking and lifetime non-smokers, adjusted for occupational exposure.

Entities:  

Mesh:

Year:  1996        PMID: 8834553     DOI: 10.1097/00001648-199603000-00007

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  9 in total

1.  Simple optimal weighting of cases and controls in case-control studies.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2008-09-29       Impact factor: 0.968

2.  Imputation approaches for potential outcomes in causal inference.

Authors:  Daniel Westreich; Jessie K Edwards; Stephen R Cole; Robert W Platt; Sunni L Mumford; Enrique F Schisterman
Journal:  Int J Epidemiol       Date:  2015-07-25       Impact factor: 7.196

3.  From exposures to population interventions: pregnancy and response to HIV therapy.

Authors:  Daniel Westreich
Journal:  Am J Epidemiol       Date:  2014-02-25       Impact factor: 4.897

4.  Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.

Authors:  Sheena G Sullivan; Eric J Tchetgen Tchetgen; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2016-09-01       Impact factor: 4.897

5.  A basic study design for expedited safety signal evaluation based on electronic healthcare data.

Authors:  Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-08       Impact factor: 2.890

6.  A pseudo-likelihood method for estimating misclassification probabilities in competing-risks settings when true-event data are partially observed.

Authors:  Philani B Mpofu; Giorgos Bakoyannis; Constantin T Yiannoutsos; Ann W Mwangi; Margaret Mburu
Journal:  Biom J       Date:  2020-06-10       Impact factor: 2.207

7.  Genome-wide association scans for secondary traits using case-control samples.

Authors:  Genevieve M Monsees; Rulla M Tamimi; Peter Kraft
Journal:  Genet Epidemiol       Date:  2009-12       Impact factor: 2.135

8.  Cluster-Randomized Test-Negative Design Trials: A Novel and Efficient Method to Assess the Efficacy of Community-Level Dengue Interventions.

Authors:  Katherine L Anders; Zoe Cutcher; Immo Kleinschmidt; Christl A Donnelly; Neil M Ferguson; Citra Indriani; Peter A Ryan; Scott L O'Neill; Nicholas P Jewell; Cameron P Simmons
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

9.  A regression model for risk difference estimation in population-based case-control studies clarifies gender differences in lung cancer risk of smokers and never smokers.

Authors:  Stephanie A Kovalchik; Sara De Matteis; Maria Teresa Landi; Neil E Caporaso; Ravi Varadhan; Dario Consonni; Andrew W Bergen; Hormuzd A Katki; Sholom Wacholder
Journal:  BMC Med Res Methodol       Date:  2013-11-19       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.